Walgreens Boots Alliance, Inc.
WBADelisted- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001618921
Walgreens Boots Alliance, Inc. was delisted in 2025; its insiders filed their last Form 4 on Aug 28, 2025; 808 institutions reported holding it in 13F filings for Q2 2025, worth $6.28B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 808
- Q2 2025, −35 vs. previous quarter
- 13F value
- $6.26B
- Reported value at the end of Q2 2025
- Superinvestors holding
- 1
- At the end of Q2 2025
Superinvestors holding WBA, Q2 2025
1 superinvestor reports holding Walgreens Boots Alliance, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
0.1%
Walgreens Boots Alliance, Inc.'s share of the portfolio
- Shares
- 750,000
- Value
- $8.61M
Latest insider trades
Open-market purchases and sales by Walgreens Boots Alliance, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 (view filing) | Apr 27 | 2 days | Pessina StefanoExecutive Chairman of Board | SSaleCommon Stock, par value $0.01 per share | −832.3K | $11.01 | −$9.16M | −55.9%657.3K after | |
| Apr 29, 2025 (view filing) | Apr 27 | 2 days | Pessina StefanoExecutive Chairman of Board | PPurchaseCommon Stock, par value $0.01 per share | +832.3K | $11.01 | +$9.16M | +0.6%145.6M after | |
| Apr 15, 2024 (view filing) | Apr 11 | 4 days | Bhandari Inderpal SDirector | PPurchase | +3.00K | $18.05 | +$54.1K | New position3.00K after | |
| Apr 2, 2024 (view filing) | Apr 2 | Same day | Mahajan ManmohanEVP and Global CFO | PPurchase | +6.00K | $19.38 | +$116.3K | +3.7%167.0K after | |
| Jan 31, 2024 (view filing) | Jan 29 | 2 days | Jarrett Valerie BDirector | PPurchase | +4.46K | $22.44 | +$100.0K | New position4.46K after | |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Schlichting Nancy MDirector | SSale | −15.2K | $23.05 | −$350.6K | −100.0%0 after | |
| Jan 8, 2024 (view filing) | Jan 5 | 3 days | Wentworth Timothy CChief Executive Officer | PPurchase | +10.0K | $24.22 | +$242.2K | +1.7%585.1K after | |
| Nov 14, 2023 (view filing) | Nov 10 | 4 days | Gates Richard P.SVP, Chief Pharmacy Officer | SSale | −1.00K | $20.45 | −$20.4K | −1.3%73.9K after | |
| Jul 5, 2023 (view filing) | Jun 30 | 5 days | Driscoll John PatrickEVP, Pres. U.S. Healthcare | PPurchase | +5.17K | $28.42 | +$147.0K | +9.6%59.0K after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Brewer Rosalind GCEO | PPurchase | +10.0K | $33.95 | +$339.5K | +2.8%369.9K after |
Top 10 13F holders, Q2 2025
The largest institutional positions in Walgreens Boots Alliance, Inc. at the end of Q2 2025; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 83,119,485 | $954.2M | 0.02% | −253,210−0.3% | Reduced |
| BlackRock, Inc. | 51,366,742 | $589.7M | 0.01% | −9,391,438−15.5% | Reduced |
| State Street Corp | 32,243,219 | $370.2M | 0.01% | −3,331,126−9.4% | Reduced |
| UBS Oconnor LLC | 25,115,686 | $288.3M | 7.87% | +15,003,457+148.4% | Added |
| Invesco Ltd. | 23,141,239 | $265.7M | 0.05% | −75,658−0.3% | Reduced |
| FMR LLC | 22,216,576 | $255.0M | 0.01% | +10,051,039+82.6% | Added |
| FIL Ltd | 20,609,000 | $236.6M | 0.20% | +20,609,000 | New |
| Geode Capital Management, LLC | 19,186,400 | $219.9M | 0.02% | +205,669+1.1% | Added |
| Norges Bank | 17,272,849 | $198.3M | 0.02% | +7,545,008+77.6% | Added |
| Charles Schwab Investment Management Inc | 15,322,383 | $175.9M | 0.03% | +741,556+5.1% | Added |